nitroglycerin has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, MN | 1 |
| Burgess, C | 1 |
1 other study available for nitroglycerin and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Management of Calcium Hydroxyapatite Vascular Occlusion in a Hemophiliac With HIV-Associated Facial Lipoatrophy.
Topics: Administration, Cutaneous; Combined Modality Therapy; Dermal Fillers; Durapatite; Face; Facial Derma | 2021 |